Accepting Applications for the ANA Innovation Awards, powered by BD
CONTACT:
Rachel Farbman, 301-628-5062
rachel.farbman@ana.org
Shannon McClendon, 301-628-5391
shannon.mcclendon@ana.org
Silver Spring, MD— The American Nurses Association (ANA) and the American Nurses Foundation (the Foundation) are proud to launch the ANA Innovation Awards, powered by BD (Becton, Dickinson and Company), a leading global medical technology company. These awards will highlight and recognize nurse-led innovation that improves patient safety and outcomes.
“We are excited to announce the launch of this new program. The ANA Innovation Awards will play a critical role in advancing and celebrating nursing innovation,” said ANA Enterprise CEO Loressa Cole, DNP, MBA, RN, NEA-BC, FACHE. “We look forward to seeing the influential work nurses are producing to improve nursing practice and the delivery of quality patient care.”
The ANA Innovation Awards will be presented to an individual nurse and to a nurse-led team whose projects best exemplify nurse-led innovation. The awards include a $25,000 individual award and a $50,000 team award to support the use of translational research, development, prototyping, production, testing and implementation for a product, program, project, or practice transformative to patient safety and/or outcomes.
“BD is thrilled to support the ANA Innovation Awards and the approximately 4 million registered nurses in the U.S. who are on the front lines of providing critical care to patients in need," said Kelly Larrabee Robke, RN, MBA, MS, Vice President of Nursing Engagement for Medication Management Solutions for BD. “This award embodies everything we strive to achieve in reinventing medication management through the evolution of care and we applaud the ANA for establishing a program that awards innovation to address challenges in health care.”
BD’s generous contribution to the Foundation is in direct support of the ANA Innovation Awards program for the next three years. Award recipients will have one year to further develop their innovation and will return to present their project outcomes at the following year’s ANA Quality & Innovation Conference.
Applications will be accepted through December 31, 2018 and evaluated by a blind, peer review process conducted by a panel of national experts. For more information about the awards criteria and how to apply, visit www.nursingworld.org/aia.
# # #
About the ANA Enterprise
The ANA Enterprise is the organizing platform of the American Nurses Association (ANA), the American Nurses Credentialing Center (ANCC), and the American Nurses Foundation. The ANA Enterprise leverages the combined strength of each to drive excellence in practice and ensure nurses’ voice and vision are recognized by policy leaders, industry influencers and employers. From professional development and advocacy, credentialing and grants, and products and services through its Nursing Knowledge Center division, the ANA Enterprise is the leading resource for nurses to arm themselves with the tools, information, and network they need to excel in their individual practices. In helping individual nurses succeed—across all practices and specialties, and at each stage of their careers—the ANA Enterprise is lighting the way for the entire profession to succeed.
For high resolution images of the ANA Enterprise logo or photos of ANA Enterprise leadership, please click here.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to better diagnose disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com.